{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:57:48Z","timestamp":1791262668494,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/ejhg.2016.57","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T11:02:25Z","timestamp":1465383745000},"page":"1591-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Sensitivity of BRCA1\/2 testing in high-risk breast\/ovarian\/male breast cancer families: little contribution of comprehensive RNA\/NGS panel testing"],"prefix":"10.1038","volume":"24","author":[{"given":"Helen","family":"Byers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke M","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Reay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Gareth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"BFejhg201657_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1399-0004.2012.01859.x","volume":"82","author":"F Lalloo","year":"2012","unstructured":"Lalloo F, Evans DG : Familial breast cancer. Clin Genet 2012; 82: 105\u2013114.","journal-title":"Clin Genet"},{"key":"BFejhg201657_CR2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C et al: BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 2012; 30: 2654\u20132663.","journal-title":"J Clin Oncol"},{"key":"BFejhg201657_CR3","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/bcr3493","volume":"15","author":"SA Eccles","year":"2013","unstructured":"Eccles SA, Aboagye EO, Ali S et al: Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 2013; 15: R92.","journal-title":"Breast Cancer Res"},{"key":"BFejhg201657_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C et al: Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010; 42: 410\u2013414.","journal-title":"Nat Genet"},{"key":"BFejhg201657_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/ng.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E et al: Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 2011; 43: 879\u2013882.","journal-title":"Nat Genet"},{"key":"BFejhg201657_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"C Loveday","year":"1998","unstructured":"Loveday C, Turnbull C, Ruark E et al: Germline RAD51C mutations confer susceptibility to ovarian cancer. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676\u2013689.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201657_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10549-012-2130-5","volume":"134","author":"MJ Smith","year":"2012","unstructured":"Smith MJ, Gifford FL, Lalloo F, Newman WG, Evans DG : High sensitivity for BRCA1\/2 mutations in breast\/ovarian kindreds: are there still other breast\/ovary genes to be discovered? Breast Cancer Res Treat 2012; 134: 895\u2013897.","journal-title":"Breast Cancer Res Treat"},{"key":"BFejhg201657_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/jmg.2009.067850","volume":"46","author":"DG Evans","year":"2009","unstructured":"Evans DG, Lalloo F, Cramer et al: Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 2009; 46: 811\u2013817.","journal-title":"J Med Genet"},{"key":"BFejhg201657_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1399-0004.2008.00974.x","volume":"73","author":"DGR Evans","year":"2008","unstructured":"Evans DGR, Young K, Bulman M, Shenton A, Lalloo F : Probability of BRCA1\/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families. Clin Genet 2008; 73: 338\u2013345.","journal-title":"Clin Genet"},{"key":"BFejhg201657_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jmg.2006.043091","volume":"44","author":"A Smith","year":"2007","unstructured":"Smith A, Moran A, Boyd MC et al: The trouble with phenocopies: are those testing negative for a family BRCA1\/2 mutation really at population risk? J Med Genet 2007; 44: 10\u201315.","journal-title":"J Med Genet"},{"key":"BFejhg201657_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","volume":"15","author":"LM Messiaen","year":"2000","unstructured":"Messiaen LM, Callens T, Mortier G et al: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000; 15: 541\u2013555.","journal-title":"Hum Mutat"},{"key":"BFejhg201657_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jmg.2006.047753","volume":"44","author":"DGR Evans","year":"2007","unstructured":"Evans DGR, Ramsden RT, Shenton et al: Mosaicism in NF2 an update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including. MLPA J Med Genet 2007; 44: 424\u2013428.","journal-title":"MLPA J Med Genet"},{"key":"BFejhg201657_CR13","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1158\/1078-0432.CCR-12-1100","volume":"18","author":"O Anczuk\u00f3w","year":"2012","unstructured":"Anczuk\u00f3w O, Buisson M, L\u00e9on\u00e9 M et al: BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy. Clin Cancer Res 2012; 18: 4903\u20134909.","journal-title":"Clin Cancer Res"},{"key":"BFejhg201657_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/ejhg.2009.89","volume":"17","author":"V Caux-Moncoutier","year":"2009","unstructured":"Caux-Moncoutier V, Pag\u00e8s-Berhouet S, Michaux D et al: Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study. Eur J Hum Genet 2009; 17: 1471\u20131480.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201657_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T et al: Breast-cancer risk in families with mutations in PALB2. N Engl J Med 2014; 371: 497\u2013506.","journal-title":"N Engl J Med"},{"key":"BFejhg201657_CR16","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG et al: Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 2011; 13: R73.","journal-title":"Breast Cancer Res"},{"key":"BFejhg201657_CR17","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC et al: Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 2015; 372: 2243\u20132257.","journal-title":"N Engl J Med"},{"key":"BFejhg201657_CR18","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"DM Eccles","year":"2008","unstructured":"Eccles DM, Easton D, Foulkes WD et al: Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 2008; 29: 1282\u20131291.","journal-title":"Hum Mutat"},{"key":"BFejhg201657_CR19","unstructured":"Wallis Y, Payne S, McAnulty C et al: Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics, Available from http:\/\/www.acgs.uk.com\/media\/774853\/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201657","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:37Z","timestamp":1684430257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["BFejhg201657"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.57","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]},"assertion":[{"value":"31 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}